Cargando…
Efficient suppression of endogenous CFTR nonsense mutations using anticodon-engineered transfer RNAs
Nonsense mutations or premature termination codons (PTCs) comprise ∼11% of all genetic lesions, which result in over 7,000 distinct genetic diseases. Due to their outsized impact on human health, considerable effort has been made to find therapies for nonsense-associated diseases. Suppressor tRNAs h...
Autores principales: | Ko, Wooree, Porter, Joseph J., Sipple, Matthew T., Edwards, Katherine M., Lueck, John D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9126842/ https://www.ncbi.nlm.nih.gov/pubmed/35664697 http://dx.doi.org/10.1016/j.omtn.2022.04.033 |
Ejemplares similares
-
Therapeutic promise of engineered nonsense suppressor tRNAs
por: Porter, Joseph J., et al.
Publicado: (2021) -
Anticodon table of the chloroplast genome and identification of putative quadruplet anticodons in chloroplast tRNAs
por: Mohanta, Tapan Kumar, et al.
Publicado: (2023) -
Engineered tRNAs suppress nonsense mutations in cells and in vivo
por: Albers, Suki, et al.
Publicado: (2023) -
Engineered transfer RNAs for suppression of premature termination codons
por: Lueck, John D., et al.
Publicado: (2019) -
Repurposing tRNAs for nonsense suppression
por: Albers, Suki, et al.
Publicado: (2021)